Journal: Molecular Medicine Reports
Article Title: Loss of RUNX3 is significantly associated with advanced tumor grade and stage in endometrial cancers
doi: 10.3892/mmr.2018.8915
Figure Lengend Snippet: (A) Expression patterns of RUNX3 mRNA in two normal endometrial tissues, two endometrial cancer tissues, and two endometrial cancer cell lines, as determined by reverse-transcription-PCR. GAPDH was used as a standard reference (B) Methylation-specific PCR for the two endometrial cancer cell lines, HEC1-α and Ishikawa. RUNX3, runt-related transcription factor 3; PCR, polymerase chain reaction; N, normal endometrial tissue; T, endometrial cancer tissue; M, methylated; U, unmethylated; PC, positive control; NC, negative control.
Article Snippet: To block endogenous peroxidase, the sections were incubated in 3% hydrogen peroxide in methanol at room temperature for 20 min. Next, sections were washed three times with distilled water, soaked in PBS pH 7.4 for 3 min, and then incubated with rabbit polyclonal antibody against human RUNX3 (39301; 1:100; Active Motif, Inc., Carlsbad, CA, USA) at room temperature for 1 h. Sections were washed with PBS three times for 3 min each and then were incubated with secondary antibody EnVision HRP-Labelled Polymer anti-rabbit (K4002; Dako; Agilent Technologies, Inc., Santa Clara, CA, USA) for 30 min at room temperature.
Techniques: Expressing, Reverse Transcription, Methylation, Polymerase Chain Reaction, Positive Control, Negative Control